Ethypharm announces the commercial launch in the US of a new product using its Flashtab® technology. Tramadol Flashtab® is available since end of May, 2010. This new commercial launch confirms Ethypharm’s strong commitment to increase its presence on the North American market.
News and Press Release
July 2010 – Ethypharm launches a new product on the US market
April 2010 – Joint Press Release : Colorcon Acquires NP Pharm
Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This acquisition expands Colorcon’s global excipient product offerings in the pharmaceutical and nutritional markets.
April 2010 – Ethypharm sells its subsidiary NP Pharm
Ethypharm announces the cession of its subsidiary NP PHARM to COLORCON, a company dedicated to the development, supply and technical support of formulated coatings and excipients for the pharmaceutical industry.
April 2010 – Ethypharm moves R&D activities from Canada to France
Ethypharm announces the cession of its R&D center in Laval (Montreal), Canada. The R&D center of Laval, certified by both Canadian and American Health Authorities, was dedicated to the development of oral modified release form medicines and employed 31 people.
February 2010 – Hugues Lecat appointed Chairman and CEO of Ethypharm
M. Hugues Lecat has been appointed Chairman and Chief Executive Officer of the Management Board of the pharmaceutical company Ethypharm.
January 2010 – Axorid ® : further collaboration with Meda
Ethypharm and Meda have just spread their collaboration for the marketing of Axorid ® in Eastern Europe. This “once a day” formulation is the first fixed association of ketoprofen with omeprazole, developed by Ethypharm. The first agreement, signed in 2007, concerned Western and Central Europe.
October 2009 – Launching of Oxycodone Flashtab®
October 2009, Paris – France : Ethypharm announce the launch, by Mundipharma, in France and in Germany of an Orodispersible form of Oxycodone marketed under the name of OxynormOro® and Oxynorm Dispersa®.
September 2009 – FDA concludes inspections at two facilities
Ethypharm, a pharmaceutical technology based company, announced that United States Food and Drug Administration (FDA) recently completed two Inspections at its manufacturing facilities.
April 2009 – Ethypharm and Archimedes expand collaboration
ETHYPHARM announced it has signed two agreements with the pan-European company Archimedes Pharma Limited.
